The breast was the most common site of a new malignancy for early-stage OC; this phenomenon might be due to (1) breast cancer being the most common cancer in women, and (2) the fact that the occurrence of ovarian and breast cancers shares the same risk exposure of a genetic mutation in either BRCA1 or BRCA2 (22, 23). This evidence concerns the gene BRCA2 and cancer.